Literature DB >> 11928820

Nervous system pathology: the fibrin perspective.

Katerina Akassoglou1, Sidney Strickland.   

Abstract

Studies of extracellular matrix (ECM) biology in the nervous system have mainly focused on laminin, fibronectin and tenascin-R, proteins that are present during nervous system development and normal function. However, during disease, fibrin, which physiologically is not present in the nervous tissue, is detected at nervous tissue lesions. This review summarizes evidence that correlates fibrin deposition with neuropathology and presents recent findings on cellular mechanisms and intracellular signaling pathways regulated by fibrin that might contribute to nervous system disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11928820     DOI: 10.1515/BC.2002.004

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  21 in total

1.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 2.  Fibrinogen signal transduction in the nervous system.

Authors:  J K Ryu; D Davalos; K Akassoglou
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

3.  Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells.

Authors:  Wendy M Campana; Elisabetta Mantuano; Pardis Azmoon; Kenneth Henry; Michael A Banki; John H Kim; Donald P Pizzo; Steven L Gonias
Journal:  FASEB J       Date:  2017-01-10       Impact factor: 5.191

Review 4.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

5.  Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.

Authors:  Katerina Akassoglou; Ryan A Adams; Jan Bauer; Peter Mercado; Vivian Tseveleki; Hans Lassmann; Lesley Probert; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

6.  Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients.

Authors:  Pradeep K Singh; Zu-Lin Chen; Dhiman Ghosh; Sidney Strickland; Erin H Norris
Journal:  Neurobiol Dis       Date:  2020-03-12       Impact factor: 5.996

Review 7.  Fibrinogen and Neuroinflammation During Traumatic Brain Injury.

Authors:  Nurul Sulimai; David Lominadze
Journal:  Mol Neurobiol       Date:  2020-08-10       Impact factor: 5.590

8.  Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.

Authors:  Christian Schachtrup; Paul Lu; Leonard L Jones; Jae K Lee; Jerry Lu; Ben D Sachs; Binhai Zheng; Katerina Akassoglou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

9.  A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.

Authors:  Emma East; David Baker; Gareth Pryce; H Roger Lijnen; M Louise Cuzner; Djordje Gverić
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 10.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.